Peter James Arthur Benson
Vorsitzender bei ASCELIA PHARMA AB
Vermögen: 43 377 $ am 30.04.2024
Ursprung des Netzwerks ersten Grades von Peter James Arthur Benson
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
University of Lund
51
| College/University | Other Consumer Services | 51 |
| Public Company | Biotechnology | 29 | |
Sunstone Capital A/S
 Sunstone Capital A/S Investment ManagersFinance Sunstone Capital A/S (Sunstone) is an independent venture capital firm headquartered in Copenhagen, Denmark. The firm was founded in 2007 by Peter Benson, Sten Verland, and Søren Lemonius, and invests on behalf of a group of institutional investors.
20
| Private Company | Investment Managers | 20 |
| Public Company | Pharmaceuticals: Major | 16 | |
15
| Public Company | Medical Specialties | 15 |
Pharmacia AB
7
| Extinct | Pharmaceuticals: Major | 7 |
PainDrainer AB
 PainDrainer AB Packaged SoftwareTechnology Services PainDrainer AB is a Swedish medical technology company that helps people with chronic pain achieve a better quality of life and activity balance. The company is based in Lund, Sweden. The company's app is based on seven categories that have a scientifically proven impact on pain levels. Users can choose what they want to do more of in their lives, and the app helps them achieve their goals. PainDrainer has been shown to have a scientifically documented effect in many clinical studies and is a CE-marked medical technical app. The CEO of the company is Erik Frick.
6
| Holding Company | Packaged Software | 6 |
Kabi Pharmacia
6
| Private Company | 6 | |
| Public Company | Pharmaceuticals: Major | 6 | |
Sunstone LSV Management A/S
2
| Subsidiary | 2 | |
Sunstone LSV General Partner I ApS
2
| Private Company | 2 | |
Sunstone LSV General Partner BI ApS
2
| Private Company | 2 | |
Ascelia Incentive AB
2
| Private Company | 2 | |
Sunstone LSV GP BI Holding ApS
1
| Private Company | 1 | |
Sunstone LSV Special Limited Partner III Aps
1
| Private Company | 1 | |
Sunstone Lsv Partners Holding ApS
1
| Private Company | 1 | |
Sunstone LSV Invest III ApS
1
| Private Company | 1 | |
Sunstone LSV Gp I Holding ApS
1
| Private Company | 1 | |
Sunstone LSV Special LP II Holding Aps
1
| Private Company | 1 | |
CMC SPV of 3 April 2017 AB
1
| Subsidiary | 1 | |
Azanta A/S
 Azanta A/S Pharmaceuticals: MajorHealth Technology Azanta A/S develops pharmaceutical drugs for medical treatments in women´s health, oncology and addiction medicine. Its products include Angusta, which helps in cervical ripening and induction of labor. The firm also develops drugs for the treatment of head and neck cancer patients undergoing with radiotherapy. The company was founded by Claus Juan Møller-San Pedro and Jan Andersen in 1994 and is headquartered in Valby, Denmark.
1
| Subsidiary | Pharmaceuticals: Major | 1 |
Sunstone Lsv Partners & Co. Holding ApS
1
| Private Company | 1 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Peter James Arthur Benson
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| University of Copenhagen | College/University | Doctorate Degree Graduate Degree Corporate Officer/Principal Doctorate Degree Undergraduate Degree Graduate Degree Graduate Degree Doctorate Degree | |
| University of Uppsala | College/University | Masters Business Admin Graduate Degree Graduate Degree Undergraduate Degree Doctorate Degree Masters Business Admin Doctorate Degree | |
Atlas Therapeutics AB
 Atlas Therapeutics AB Pharmaceuticals: MajorHealth Technology Part of Alligator Bioscience AB, Atlas Therapeutics AB develops and manufactures antibody drugs. The company is based in Stockholm, Sweden. Atlas Therapeutics was acquired by Alligator Bioscience AB on October 18, 2013. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member Chairman Director/Board Member Director/Board Member Chairman | |
Danmarks Eksport- og Investeringsfond
 Danmarks Eksport- og Investeringsfond Investment ManagersFinance Danmarks Eksport- og Investeringsfond (EIFO) is a venture capital subsidiary of Government of Denmark and founded in 1992. The firm is headquartered in Hellerup, Denmark. | Investment Managers | Head-Equity Investments Private Equity Investor Private Equity Investor Private Equity Investor Chief Investment Officer | |
| A Bioscience Incentive AB | Chairman Chairman Director/Board Member Director/Board Member Director/Board Member | ||
| Copenhagen Business School | College/University | Graduate Degree Graduate Degree Masters Business Admin Graduate Degree | |
| University of Stockholm | College/University | Graduate Degree Undergraduate Degree Undergraduate Degree Graduate Degree | |
| NOVO NORDISK A/S | Pharmaceuticals: Major | Corporate Officer/Principal Chief Investment Officer Corporate Officer/Principal Corporate Officer/Principal | |
| HQ AB | Investment Banks/Brokers | Director of Finance/CFO Chairman President Director/Board Member | |
| Royal Institute of Technology | College/University | Corporate Officer/Principal Graduate Degree Doctorate Degree Doctorate Degree | |
Symphogen A/S
 Symphogen A/S Pharmaceuticals: MajorHealth Technology Symphogen A/S provides antibody therapeutics for the treatment of cancers. It offers oncology products and creates selected antibody mixtures that address multiple oncology targets in a single drug product. The firm’s pipeline is fueled by its technology suite capable of identifying, selecting, manufacturing, and characterizing optimal antibody mixtures. The company was founded by Kirsten Aarup Drejer, Thomas Feldthus, Eigil Bjerl Nielsen, Anker Gunvald Lundemose, Kim Arthur Hueg, and John Soerensen Haurum in 2000 and is headquartered in Ballerup, Denmark. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Chief Operating Officer | |
Ericsson AB
 Ericsson AB Information Technology ServicesTechnology Services Ericsson AB manufactures and markets telecommunications equipment and solutions for corporate, as well as individual clients. It develops, sells, and trades goods, products, and services in the field of radio technology. The company was founded in 1952 and is headquartered in Kista, Sweden. | Information Technology Services | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
SwedenBIO Service AB
 SwedenBIO Service AB Miscellaneous Commercial ServicesCommercial Services SwedenBIO Service AB is a non-profit company that develops biotechnology, diagnostics, pharmaceuticals, and medical technology. It also offers counseling, education, opinion formation, and investigations. The company was founded in 2002 and is headquartered in Stockholm, Sweden. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member | |
| BIOINVENT INTERNATIONAL AB | Biotechnology | Founder Investor Relations Contact Director/Board Member | |
| Heartcore Capital A/S | Investment Managers | Founder Private Equity Investor Director of Finance/CFO | |
| Karolinska Institutet | College/University | Doctorate Degree Undergraduate Degree Corporate Officer/Principal | |
| IRLAB THERAPEUTICS AB | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
| Chalmers University of Technology | College/University | Graduate Degree Graduate Degree Graduate Degree | |
| MEDCAP AB | Medical Specialties | Chief Investment Officer Chief Executive Officer Corporate Officer/Principal | |
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Miscellaneous Commercial Services | Chief Executive Officer Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Oblique Therapeutics AB
 Oblique Therapeutics AB Pharmaceuticals: MajorHealth Technology Oblique Therapeutics AB is a privately held Swedish biotech company that develops innovative new medicines for severe diseases with a large unmet medical need, focusing on pain and advanced cancer. The company is based in Gothenburg, Sweden. The company uses abiprot®, an in-house-invented, next-generation antibody platform that can generate antibodies with programmed function against the full human proteome. The portfolio comprises several antibody candidates and the small molecule ot-1096 in triple-negative breast cancer. In addition, two antibody programs are run in R&D collaborations with pharma companies. The company was founded in 2015 by Jan Owe Owesson Orwar, and Christer Nordstedt has been the CEO of the company since 2022. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
| Handelshögskolan i Göteborg | College/University | Undergraduate Degree Masters Business Admin Graduate Degree | |
| BIOTAGE AB | Medical Specialties | Founder Founder Director/Board Member | |
Royal Swedish Academy of Engineering Sciences
 Royal Swedish Academy of Engineering Sciences Miscellaneous Commercial ServicesCommercial Services The Royal Swedish Academy of Engineering Sciences (IVA) is an organization that brings together around 1,300 academy members and 250 companies to bridge the gap between academia, business, and politics. The non-profit company is based in Stockholm, Sweden. The Swedish company's aim is to work towards people's ability to contribute positively to society. The organization runs an internship program called Tekniksprånget, which gives young people in Sweden the opportunity to test the engineering profession through a four-month paid internship. The program has been running since 2012 and aims to inspire more people to choose a higher technical education. The CEO of the company is Björn O. Nilsson. | Miscellaneous Commercial Services | Corporate Officer/Principal Director/Board Member Corporate Officer/Principal | |
| Pulsetten AB | Director/Board Member Director/Board Member | ||
PricewaterhouseCoopers AB
 PricewaterhouseCoopers AB Miscellaneous Commercial ServicesCommercial Services PricewaterhouseCoopers AB provides auditing services. It also specializes in capital markets, tax systems, and finance. The company was founded on October 15, 1958 and is headquartered in Stockholm, Sweden. | Miscellaneous Commercial Services | Comptroller/Controller/Auditor Corporate Officer/Principal | |
ApoEx AB
 ApoEx AB Medical DistributorsDistribution Services ApoEx AB offers products and services to healthcare industry. The firm provides services for dentistry, aesthetic surgery and medical care, animal care, and government. The company was founded by Jens-Leo Hubertus Berlips and John Patrick Berlips in 2010 and is headquartered in Stockholm, Sweden. | Medical Distributors | Director/Board Member Director of Finance/CFO | |
Egalet Ltd.
 Egalet Ltd. Pharmaceuticals: MajorHealth Technology Egalet Ltd. engages in manufacturing of basic pharmaceutical products. It focuses on the commercialization and development of abuse resistant formulations of opioids and other pain care drugs. The company was founded on July 15, 2010 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Nobel Biocare AB
 Nobel Biocare AB Medical SpecialtiesHealth Technology Nobel Biocare AB provides esthetic dental solutions. The firm offers crown, bridge and implant products, as well as training & education and clinically documented treatment concepts. Its solutions enable dental specialists, general practitioners and dental technicians to offer patients esthetic new teeth. The company is headquartered in Goteborg, Sweden. | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal | |
Affibody AB
 Affibody AB Miscellaneous Commercial ServicesCommercial Services Affibody AB conducts research and development services within biotechnology. It markets and sells licensed products and research findings to the pharmaceutical industry. The company was founded by Karin Nord in 1998 and is headquartered in Stockholm, Sweden. | Miscellaneous Commercial Services | Founder Director/Board Member | |
| BOULE DIAGNOSTICS AB | Medical Specialties | Director/Board Member Chief Executive Officer | |
| SCANDIDOS AB | Packaged Software | Director/Board Member Director/Board Member | |
Inter Life Science AB
 Inter Life Science AB Financial ConglomeratesFinance Part of Catella AB, Inter Life Science AB is a Swedish company that provides investment services. The company is based in Stockholm, Sweden and was founded in 2004. | Financial Conglomerates | Director/Board Member Director/Board Member | |
| IMMUNOVIA AB | Pharmaceuticals: Major | Founder Director/Board Member | |
| ASTRAZENECA PLC | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
F2G Ltd.
 F2G Ltd. Pharmaceuticals: MajorHealth Technology F2G Ltd. provides novel drugs for the treatment of life-threatening systemic fungal diseases. It primarily focuses on developing an F3 series of anti mould compound, which is an antifungal agent that acts through a mechanism different from marketed drugs. The company was founded in 1998 and is headquartered in Manchester, the United Kingdom. | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member | |
| VICORE PHARMA HOLDING AB | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
| Technical University of Denmark | College/University | Corporate Officer/Principal Graduate Degree | |
Affibody Medical AB
 Affibody Medical AB Pharmaceuticals: MajorHealth Technology Affibody Medical AB provides biopharmaceuticals services. It develops Affibody, an antibody mimetic and Albumod, a technology that enhances the efficacy of biopharmaceuticals by extending their circulatory half-life through a strong binding to albumin. The company was founded by Karin Nord and Carl Erik Mathias Uhlén in 1998 and is headquartered in Stockholm, Sweden. | Pharmaceuticals: Major | Founder Director/Board Member | |
| ACTIVE BIOTECH AB | Biotechnology | Public Communications Contact General Counsel | |
Atlas Antibodies AB
 Atlas Antibodies AB BiotechnologyHealth Technology Atlas Antibodies AB develops antibodies and reagents for Mass Spectrometry (MS)-based quantitative proteomics. Its project Human Protein Atlas aim to present an expression map of the complete human proteome. It offers characterized antibodies to various protein coding human genes; Triple A Polyclonals that are research grade rabbit polyclonal antibodies; and mouse monoclonal antibodies to selected proteins, as a complement to rabbit polyclonal antibodies. Its antibodies are used to study human proteins, for basic research purposes and clinical research in various disease areas, such as cancer and neurological brain diseases. The company was founded by Jan Fredrik Pontén, Karin Marianne Hansson, Henrik Wernérus, and Carl Erik Mathias Uhlén in 2006 and is headquartered in Stockholm, Sweden. | Biotechnology | Founder Director/Board Member | |
| WNTRESEARCH AB | Pharmaceuticals: Other | Director/Board Member Chief Executive Officer | |
| EUROCINE VACCINES AB | Pharmaceuticals: Major | Director/Board Member Chairman | |
| BOOZT AB | Catalog/Specialty Distribution | Director/Board Member Director/Board Member |
Statistik
International
| Schweden | 38 |
| Dänemark | 11 |
| Vereinigtes Königreich | 4 |
Sektoral
| Health Technology | 25 |
| Consumer Services | 10 |
| Commercial Services | 6 |
| Finance | 5 |
| Technology Services | 3 |
Operativ
| Director/Board Member | 669 |
| Chairman | 202 |
| Corporate Officer/Principal | 171 |
| Chief Executive Officer | 106 |
| Independent Dir/Board Member | 96 |
Am stärksten vernetzte Beziehungen
- Börse
- Insiders
- Peter James Arthur Benson
- Unternehmensverbindungen
